學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
Good Shepherd Pharmacy and RemediChain: Will this Blockchain Deliver Donated Drugs to Needy Patients?
內容大綱
In May 2019 Memphis-based pharmacist and social entrepreneur Phil Baker hopes coding will start soon on blockchain software and related applications that will enable efficient and secure collection of usable drugs from individual donors and redistribution to needy authorized patients. To reach this point, he founded the subscription-based Good Shepherd charitable pharmacy, which bypasses pharmacy industry middlemen to sell medications at low prices, and distribute free donated drugs. Next, he successfully lobbied for passage of a Tennessee law that allows medications to be donated by individuals from anywhere in the US, to be redispensed to Tennessee patients, prioritized by need. After forming RemediChain LLC, recruiting a software development team, conducting some pilot tests to verify how to attract willing donors and needy patients, and launching the design phase for the blockchain system architecture, he formed a small consortium of pharmacy schools and other health-care organizations, in anticipation of further pilot-testing. Now, he wants to identify and plan how to mitigate foreseeable blockchain system project challenges before the system architecture and key elements are designed and software development begins. Since his two organizations (RemediChain LLC and Good Shepherd Pharmacy) are under financial pressure, and he wants to move forward quickly on building a scalable solution.